41 related articles for article (PubMed ID: 27686177)
1. Phosphohistone-H3 Proliferation Index Is Superior to Mitotic Index and MIB-1 Expression as a Predictor of Recurrence in Human Meningiomas.
Winther TL; Arnli MB; Salvesen Ø; Torp SH
Am J Clin Pathol; 2016 Oct; 146(4):510-20. PubMed ID: 27686177
[TBL] [Abstract][Full Text] [Related]
2. Significance of Staining Intensity in Ki-67 Proliferation Index in Meningiomas, and a Critical Review of the Literature on Proliferation Index Assessment.
Brasher OC; Nix JS; Gokden M
Ann Clin Lab Sci; 2024 Mar; 54(2):170-178. PubMed ID: 38802155
[TBL] [Abstract][Full Text] [Related]
3. Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early-stage luminal breast cancer.
van Steenhoven JEC; Kuijer A; Kornegoor R; van Leeuwen G; van Gorp J; van Dalen T; van Diest PJ
Histopathology; 2020 Oct; 77(4):579-587. PubMed ID: 32557844
[TBL] [Abstract][Full Text] [Related]
4. High phosphohistone H3 expression correlates with adverse clinical, biological, and pathological factors in neuroblastomas.
Ramani P; Taylor S; Miller E; Sowa-Avugrah E; May MT
J Histochem Cytochem; 2015 Jun; 63(6):397-407. PubMed ID: 25711230
[TBL] [Abstract][Full Text] [Related]
5. A rare case of sclerosing meningioma with immunohistochemical features.
Cömert D; Tosuner Z; Hatiboglu MA
Br J Neurosurg; 2023 Aug; 37(4):675-676. PubMed ID: 30681002
[TBL] [Abstract][Full Text] [Related]
6. pSlug
Woo CG; Son SM; Kim EG; Lee OJ
Int J Surg Pathol; 2023 Sep; 31(6):1021-1026. PubMed ID: 36172742
[TBL] [Abstract][Full Text] [Related]
7. Prognostic importance of mitosis quantification and PHH3 expression in oral epithelial dysplasia.
Sathyamoorthy H; Mahmood H; Zubir AZA; Hankinson P; Khurram SA
Virchows Arch; 2024 Jan; 484(1):47-59. PubMed ID: 37882821
[TBL] [Abstract][Full Text] [Related]
8. Phosphohistone H3: implications for clinical practice and risk assessment in meningioma.
Olar A
Neuro Oncol; 2015 May; 17(5):631-3. PubMed ID: 25813470
[No Abstract] [Full Text] [Related]
9. Commentary: The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma.
Dono A; Chandra A; Ballester LY; Esquenazi Y
Neurosurgery; 2021 Jun; 89(1):E66-E67. PubMed ID: 33826714
[No Abstract] [Full Text] [Related]
10. Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
Aung TM; Ngamjarus C; Proungvitaya T; Saengboonmee C; Proungvitaya S
PLoS One; 2024; 19(5):e0303337. PubMed ID: 38758750
[TBL] [Abstract][Full Text] [Related]
11. Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading.
Ibrahim A; Toss MS; Makhlouf S; Miligy IM; Minhas F; Rakha EA
Histopathology; 2023 Feb; 82(3):393-406. PubMed ID: 36349500
[TBL] [Abstract][Full Text] [Related]
12. The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?
Saffar H; Okhovat H; Arbabsoleymani S; Tavangar SM; Khoshnevisan A; Hajinasrollah G; Hamidi Afra Z; Saffar H
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2049-2052. PubMed ID: 34319026
[TBL] [Abstract][Full Text] [Related]
13. Mitotic and Proliferative Indices in WHO Grade III Meningioma.
Daniela Maier A; Brøchner CB; Bartek J; Eriksson F; Ugleholdt H; Broholm H; Mathiesen T
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33198268
[TBL] [Abstract][Full Text] [Related]
14. The prognostic role of Ki-67/MIB-1 in meningioma: A systematic review with meta-analysis.
Liu N; Song SY; Jiang JB; Wang TJ; Yan CX
Medicine (Baltimore); 2020 Feb; 99(9):e18644. PubMed ID: 32118704
[TBL] [Abstract][Full Text] [Related]
15. Automated Computational Detection, Quantitation, and Mapping of Mitosis in Whole-Slide Images for Clinically Actionable Surgical Pathology Decision Support.
Puri M; Hoover SB; Hewitt SM; Wei BR; Adissu HA; Halsey CHC; Beck J; Bradley C; Cramer SD; Durham AC; Esplin DG; Frank C; Lyle LT; McGill LD; Sánchez MD; Schaffer PA; Traslavina RP; Buza E; Yang HH; Lee MP; Dwyer JE; Simpson RM
J Pathol Inform; 2019; 10():4. PubMed ID: 30915258
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathological predictors of outcome in malignant meningioma.
Maier AD; Bartek J; Eriksson F; Ugleholdt H; Juhler M; Broholm H; Mathiesen TI
Neurosurg Rev; 2020 Apr; 43(2):643-653. PubMed ID: 30868425
[TBL] [Abstract][Full Text] [Related]
17. Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies.
Puripat N; Loharamtaweethong K
Virchows Arch; 2019 Jan; 474(1):87-96. PubMed ID: 30267302
[TBL] [Abstract][Full Text] [Related]
18. Tumor Digital Masking Allows Precise Patient Triaging: A Study Based on Ki-67 Scoring in Gastrointestinal Stromal Tumors.
Lewitowicz P; Matykiewicz J; Chrapek M; Koziel D; Horecka-Lewitowicz A; Gluszek-Osuch M; Wawrzycka I; Gluszek S
Scanning; 2018; 2018():7807416. PubMed ID: 30245762
[TBL] [Abstract][Full Text] [Related]
19. Pooling analysis on prognostic value of PHH3 expression in cancer patients.
Hao Q; Dai C; Deng Y; Xu P; Tian T; Lin S; Wang M; Liu K; Song D; Wu Y; Guo Y; Dai Z
Cancer Manag Res; 2018; 10():2279-2288. PubMed ID: 30104898
[TBL] [Abstract][Full Text] [Related]
20. The anti-apoptotic protein survivin can improve the prognostication of meningioma patients.
Winther TL; Torp SH
PLoS One; 2017; 12(9):e0185217. PubMed ID: 28953948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
